rs148378319

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_003640.5(ELP1):​c.1886G>A​(p.Arg629His) variant causes a missense change. The variant allele was found at a frequency of 0.00266 in 1,614,090 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R629C) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0020 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0027 ( 12 hom. )

Consequence

ELP1
NM_003640.5 missense

Scores

3
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:7

Conservation

PhyloP100: 4.83

Publications

11 publications found
Variant links:
Genes affected
ELP1 (HGNC:5959): (elongator acetyltransferase complex subunit 1) The protein encoded by this gene is a scaffold protein and a regulator for three different kinases involved in proinflammatory signaling. The encoded protein can bind NF-kappa-B-inducing kinase and I-kappa-B kinases through separate domains and assemble them into an active kinase complex. Mutations in this gene have been associated with familial dysautonomia. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jan 2016]
ELP1 Gene-Disease associations (from GenCC):
  • primary dysautonomia
    Inheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women's Health
  • Riley-Day syndrome
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
  • medulloblastoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_003640.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008384824).
BP6
Variant 9-108901650-C-T is Benign according to our data. Variant chr9-108901650-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 194739.
BS2
High Homozygotes in GnomAdExome4 at 12 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003640.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ELP1
NM_003640.5
MANE Select
c.1886G>Ap.Arg629His
missense
Exon 17 of 37NP_003631.2
ELP1
NM_001318360.2
c.1544G>Ap.Arg515His
missense
Exon 17 of 37NP_001305289.1A0A6Q8PGW3
ELP1
NM_001330749.2
c.839G>Ap.Arg280His
missense
Exon 15 of 35NP_001317678.1F5H2T0

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ELP1
ENST00000374647.10
TSL:1 MANE Select
c.1886G>Ap.Arg629His
missense
Exon 17 of 37ENSP00000363779.5O95163
ELP1
ENST00000537196.1
TSL:1
c.839G>Ap.Arg280His
missense
Exon 10 of 30ENSP00000439367.1F5H2T0
ELP1
ENST00000495759.6
TSL:1
n.*496G>A
non_coding_transcript_exon
Exon 11 of 31ENSP00000433514.2H0YDF3

Frequencies

GnomAD3 genomes
AF:
0.00202
AC:
308
AN:
152188
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000555
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00307
Gnomad ASJ
AF:
0.00259
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00103
Gnomad FIN
AF:
0.00122
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00301
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.00194
AC:
488
AN:
251240
AF XY:
0.00193
show subpopulations
Gnomad AFR exome
AF:
0.000677
Gnomad AMR exome
AF:
0.00162
Gnomad ASJ exome
AF:
0.00486
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00125
Gnomad NFE exome
AF:
0.00270
Gnomad OTH exome
AF:
0.00228
GnomAD4 exome
AF:
0.00273
AC:
3993
AN:
1461784
Hom.:
12
Cov.:
32
AF XY:
0.00279
AC XY:
2029
AN XY:
727198
show subpopulations
African (AFR)
AF:
0.000568
AC:
19
AN:
33474
American (AMR)
AF:
0.00183
AC:
82
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00478
AC:
125
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39696
South Asian (SAS)
AF:
0.000846
AC:
73
AN:
86258
European-Finnish (FIN)
AF:
0.00148
AC:
79
AN:
53412
Middle Eastern (MID)
AF:
0.000520
AC:
3
AN:
5768
European-Non Finnish (NFE)
AF:
0.00312
AC:
3464
AN:
1111922
Other (OTH)
AF:
0.00245
AC:
148
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.462
Heterozygous variant carriers
0
214
428
642
856
1070
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
118
236
354
472
590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00202
AC:
308
AN:
152306
Hom.:
1
Cov.:
32
AF XY:
0.00192
AC XY:
143
AN XY:
74492
show subpopulations
African (AFR)
AF:
0.000554
AC:
23
AN:
41550
American (AMR)
AF:
0.00307
AC:
47
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00259
AC:
9
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00104
AC:
5
AN:
4828
European-Finnish (FIN)
AF:
0.00122
AC:
13
AN:
10620
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00301
AC:
205
AN:
68026
Other (OTH)
AF:
0.00237
AC:
5
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
14
28
42
56
70
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00305
Hom.:
3
Bravo
AF:
0.00220
EpiCase
AF:
0.00344
EpiControl
AF:
0.00261

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
4
not provided (5)
-
2
1
Familial dysautonomia (3)
-
-
2
not specified (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.51
T
BayesDel_noAF
Benign
-0.51
CADD
Benign
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.076
T
Eigen
Benign
-0.038
Eigen_PC
Benign
0.10
FATHMM_MKL
Uncertain
0.89
D
LIST_S2
Uncertain
0.90
D
M_CAP
Benign
0.0096
T
MetaRNN
Benign
0.0084
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.6
L
PhyloP100
4.8
PrimateAI
Benign
0.38
T
PROVEAN
Benign
-1.5
N
REVEL
Benign
0.076
Sift
Benign
0.15
T
Sift4G
Benign
0.39
T
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.093
gMVP
0.46
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.090
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs148378319;
hg19: chr9-111663930;
COSMIC: COSV65897820;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.